Michael S. Weiss, Chairman and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), sold 37,344 shares at $13.70 ($524K) on 2006-12-18, disclosed to the SEC on 2006-12-18.
Scheduled sale ($524k) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.09 | 323 | $5K | 0.9% |
| 2 | $14.13 | 2,000 | $28K | 5.4% |
| 3 | $14.14 | 5,839 | $83K | 15.8% |
| 4 | $14.15 | 4,087 | $58K | 11.0% |
| 5 | $14.16 | 84 | $1K | 0.2% |
| 6 | $14.17 | 1,500 |
| $21K |
| 4.1% |
| 7 | $14.18 | 1,500 | $21K | 4.1% |
| 8 | $14.19 | 1,000 | $14K | 2.7% |
| 9 | $14.20 | 3,000 | $43K | 8.1% |
| 10 | $14.21 | 500 | $7K | 1.4% |
| 11 | $14.22 | 2,500 | $36K | 6.8% |
| 12 | $14.23 | 1,000 | $14K | 2.7% |
| 13 | $14.24 | 500 | $7K | 1.4% |
| 14 | $14.25 | 600 | $9K | 1.6% |
| 15 | $14.26 | 500 | $7K | 1.4% |
| 16 | $14.27 | 500 | $7K | 1.4% |
| 17 | $13.70 | 3,500 | $48K | 9.2% |
| 18 | $13.71 | 3,200 | $44K | 8.4% |
| 19 | $13.72 | 3,211 | $44K | 8.4% |
| 20 | $13.73 | 1,800 | $25K | 4.7% |
| 21 | $13.75 | 200 | $3K | 0.5% |
| Total | $14.03 avg | 37,344 | $524K | 100% |
| Filing → |
| FBIO | BUY | 2023-02-14 | $2.0M | — | Filing → |
| TGTX | SELL | 2022-01-07 | $2.6M | — | Filing → |
| TGTX | BUY | 2019-06-27 | $352K | — | Filing → |